Leonard Favreau

Statistics

Publications

Citations

3.9K

H-Index

Active since

1963

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

UConn Health

Merck Canada Inc. (Canada)

LabCorp (United States)

Harvard University

Leonard Favreau is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, cytochrome p450 enzymes, and pharmacy.

Publications per year

1963–2018

Publications

A New Simple Semimicro Method for Colorimetric Determination of Urea

Jean-Franҫois Coulombe, Leonard Favreau · Clinical Chemistry · 1963 · 538 citations

Agriculture, Biochemistry, Food Analysis +5

Transcriptional regulation of the rat NAD(P)H:quinone reductase gene

Leonard Favreau, C.B. Pickett · Journal of Biological Chemistry · 1991 · 500 citations · Full text

Life Sciences, Genetics, Molecular Biology +12

Inhibition of vascular smooth muscle cell growth by endothelial cell-derived heparin. Possible role of a platelet endoglycosidase.

John J. Castellot, Leonard Favreau, Morris J. Karnovsky et al. · Journal of Biological Chemistry · 1982 · 310 citations · Full text

Life Sciences, Biochemistry, Cell Biology +11

Activation of the human peripheral cannabinoid receptor results in inhibition of adenylyl cyclase.

Deborah Slipetz, Gary P. O’Neill, Leonard Favreau et al. · Molecular Pharmacology · 1995 · 194 citations

Medicine, Molecular Biology, Pharmacology +17

Purification and properties of human platelet heparitinase.

G.M. Oosta, Leonard Favreau, David Beeler et al. · Journal of Biological Chemistry · 1982 · 156 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

1–5 of 46